NCT00041678View on ClinicalTrials.gov

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

January 31, 2000

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions

Alzheimer Disease

Interventions

DRUG

aripiprazole

Trial Locations (6)

Unknown

Local Institution, Rosemead

Local Institution, Miami

Local Institution, Nashville

Local Institution, Bennington

Local Institution, Burlington

Local Institution, Milwaukee

All Listed Sponsors

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT00041678 - Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type | Biotech Hunter | Biotech Hunter